Who owns Celldex Therapeutics?

Key details on Celldex Therapeutics (Ticker: CLDX)

Who owns Celldex Therapeutics?

Is CLDX a good stock to own? Find out who bought Celldex Therapeutics, who sold Celldex Therapeutics (CLDX) stock, and who holds a large position in Celldex Therapeutics.

Fund Name Number of Shares Share Valuation As Of
FMR 11.94M $210.90M March 31, 2014
Franklin Resources 10.60M $173.02M June 30, 2014
OppenheimerFunds 8.80M $143.56M June 30, 2014
Vanguard 5.18M $84.53M June 30, 2014
Columbia Wanger Asset Management 3.58M $58.48M June 30, 2014
Jennison Associates 3.18M $51.94M June 30, 2014
BlackRock Fund Advisors 3.03M $39.32M Sept. 30, 2014
HealthCor Management 2.50M $8.88M June 30, 2011
BlackRock Institutional Trust Company, N.A. 2.41M $31.22M Sept. 30, 2014
STATE STREET CORPORATION 2.36M $38.60M June 30, 2014
OrbiMed Advisors 2.18M $35.60M June 30, 2014
TimesSquare Capital Management 2.03M $33.16M June 30, 2014
SUSQUEHANNA INTERNATIONAL 1.84M $32.52M March 31, 2014
S.A.C. Capital Advisors 1.82M $32.14M March 31, 2014
LORD, ABBETT & CO 1.69M $27.54M June 30, 2014
Wellington Management Company 1.62M $25.26M June 30, 2013
HealthCor Management 1.45M $22.63M June 30, 2013
Sectoral Asset Management 1.41M $24.90M March 31, 2014
Columbus Circle Investors 1.40M $22.86M June 30, 2014
First Eagle Investment Management 1.23M $14.24M March 31, 2013
BlackRock Advisors 1.21M $42.85M Sept. 30, 2013
NORTHERN TRUST 1.17M $20.63M March 31, 2014
TSP Capital Management 1.09M $17.03M June 30, 2013
Ridgeback Capital Investments 1.02M $24.82M Dec. 31, 2013
DIMENSIONAL FUND ADVISORS 954784 $16.87M March 31, 2014
Frontier Capital Management 922891 $15.06M June 30, 2014
ALLIANCEBERNSTEIN 908785 $22.00M Dec. 31, 2013

Who sold Celldex Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
D. E. Shaw & Co June 30, 2011 942715 $3.35M